Welcome to our dedicated page for Veradigm SEC filings (Ticker: MDRX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Veradigm Inc. SEC filings document the company’s healthcare technology business, OTC-traded common stock and formal disclosures around financial reporting, governance and capital structure. Recent filings include Current Reports on Form 8-K covering leadership appointments, preliminary financial information, material agreements and amendments to the company’s stockholder rights plan.
The filing record also includes late-filing notices for annual reports, disclosures about financial reporting and internal-control matters, board-observer and stockholder-agreement arrangements, and the conclusion of an SEC investigation without a recommended enforcement action. These filings record Veradigm’s public-company status, common stock trading symbol MDRX, rights-plan mechanics and governance changes while the company works through delayed periodic reporting.
Sacks Jonathan S reported acquisition or exercise transactions in this Form 4 filing.
Veradigm Inc. director and ten percent owner Jonathan S. Sacks reported an award of 42,507 Restricted Stock Units of common stock under the Veradigm Amended and Restated 2024 Stock Incentive Plan. The award was granted on June 1, 2026 and vests 100% on the first anniversary of the grant date.
Following this grant, Sacks holds 97,715 shares of Veradigm common stock directly. The filing also reports indirect holdings of 11,435,151 shares held by Stonehill Master Fund Ltd and 9,612,586 shares held by Stonehill Institutional Partners, L.P., entities managed by Stonehill Capital Management LLC, where Sacks is a managing member. He disclaims beneficial ownership of these securities except to the extent of any pecuniary interests.
STONEHILL CAPITAL MANAGEMENT LLC reported acquisition or exercise transactions in this Form 4 filing.
Veradigm Inc. reported an insider equity award connected to Stonehill-affiliated entities. On June 1, 2026, Jonathan Sacks received an award of 42,507 Restricted Stock Units of Veradigm common stock under the Amended and Restated 2024 Stock Incentive Plan, vesting 100% on the first anniversary of the grant date. Following this grant, Sacks is shown with 97,715 shares of common stock. Stonehill Master Fund Ltd. is reported with 11,435,151 Veradigm common shares and Stonehill Institutional Partners L.P. with 9,612,586 shares, while the reporting persons collectively disclaim beneficial ownership except for any pecuniary interests.
Veradigm Inc. director Bruce C. Felt Jr. received an equity award rather than trading shares in the market. He was granted 42,507 shares of common stock in the form of Restricted Stock Units under the Veradigm Inc. Amended and Restated 2024 Stock Incentive Plan on June 1, 2026. The footnote explains that, on the first anniversary of the grant date, all of these Restricted Stock Units will automatically convert into an equal number of Deferred Stock Units under the Veradigm Inc. Director Deferred Compensation Plan, based on an election he has made. Those Deferred Stock Units will then be settled in shares of common stock on the tenth business day of January in the year following the year in which he ceases to be a director. After this grant, Felt directly holds 97,715 shares of Veradigm common stock according to the filing.
Zierhoffer Carol J reported acquisition or exercise transactions in this Form 4 filing.
Veradigm Inc. director Carol J. Zierhoffer received an equity award of 42,507 Restricted Stock Units on June 1, 2026. The award was granted under the Veradigm Inc. Amended and Restated 2024 Stock Incentive Plan and will vest 100% on the first anniversary of the grant date.
After this grant, Zierhoffer directly holds 173,399 shares of Veradigm common stock. Because this is a compensation-related RSU award with no purchase price, it represents routine director equity compensation rather than an open-market share purchase or sale.
ASAR VINIT K reported acquisition or exercise transactions in this Form 4 filing.
Veradigm Inc. director Vinit K. Asar received an equity grant of 42,507 shares of Common Stock in the form of Restricted Stock Units on the Grant Date of June 1, 2026. The award was granted under the Veradigm Inc. Amended and Restated 2024 Stock Incentive Plan and will vest 100% on the first anniversary of the Grant Date. Following this compensation-related grant, Asar directly holds 99,131 shares of Veradigm common stock in total, with no open-market purchase or sale reported in this filing.
Rodriguez Susan reported acquisition or exercise transactions in this Form 4 filing.
Veradigm Inc. director Susan Rodriguez received a grant of 42,507 shares of Common Stock in the form of Restricted Stock Units on June 1, 2026 under the Veradigm Inc. Amended and Restated 2024 Stock Incentive Plan. The award vests 100% on the first anniversary of the grant date. After this grant, she directly holds a total of 131,125 shares of Veradigm common stock.
Veradigm Inc. director Lou Silverman reported receiving an equity grant of 42,507 shares of common stock-equivalent awards. These were granted on June 1, 2026 as Restricted Stock Units under the Veradigm Inc. Amended and Restated 2024 Stock Incentive Plan.
The RSU grant vests 100% on the first anniversary of the June 1, 2026 grant date, meaning the award must vest before the shares are fully earned. After this compensation-related acquisition, Silverman directly holds a total of 99,131 shares of Veradigm common stock.
Greyenbuhl Christian reported acquisition or exercise transactions in this Form 4 filing.
Veradigm Inc. reported that Chief Financial Officer Christian Greyenbuhl received an equity award in the form of restricted stock units. He was granted 318,809 shares of Common Stock on June 1, 2026 at a stated price of $0.00 per share, reflecting a compensation grant rather than a market purchase.
According to the footnote, the award consists of Restricted Stock Units granted under the Veradigm Inc. 2019 Stock Incentive Plan. The grant vests in four equal installments, with 1/4 of the units vesting on each of the first four anniversaries of the Grant Date. After this award, Greyenbuhl directly holds 318,809 shares reported in this filing.
Veradigm Inc. director David B. Stevens received a grant of 42,507 Restricted Stock Units (RSUs) on June 1, 2026 under the company’s 2024 Stock Incentive Plan. On the first anniversary of the grant date, all RSNs convert into an equal number of Deferred Stock Units. These Deferred Stock Units will be settled in common shares on the tenth business day of January following the calendar year in which he ceases to be a director. After this award, Stevens directly holds 163,509 shares.
Veradigm Inc. Chief Financial Officer Christian Greyenbuhl filed an initial Form 3 ownership report for the company. The filing shows he holds no shares of Veradigm common stock directly following this reporting date, and it does not record any recent purchase or sale transactions.